These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23605777)

  • 1. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.
    Gan SJ; Dahlstrom KR; Peck BW; Caywood W; Li G; Wei Q; Zafereo ME; Sturgis EM
    Cancer; 2013 Jul; 119(14):2593-601. PubMed ID: 23605777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
    Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
    J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Jin L; Sturgis EM; Zhang Y; Huang Z; Wei P; Guo W; Wang Z; Wei Q; Song X; Li G
    Carcinogenesis; 2013 Jul; 34(7):1551-7. PubMed ID: 23508638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.
    Peck BW; Dahlstrom KR; Gan SJ; Caywood W; Li G; Wei Q; Zafereo ME; Sturgis EM
    Head Neck; 2013 Jun; 35(6):794-9. PubMed ID: 22711172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.
    Li F; Sturgis EM; Zafereo ME; Liu Z; Wang LE; Wei Q; Li G
    Int J Cancer; 2009 Dec; 125(11):2660-5. PubMed ID: 19585505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck.
    Zafereo ME; Sturgis EM; Aleem S; Chaung K; Wei Q; Li G
    Cancer Prev Res (Phila); 2009 May; 2(5):432-9. PubMed ID: 19401526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Wang Z; Sturgis EM; Zhang F; Lei D; Liu Z; Xu L; Song X; Wei Q; Li G
    Mol Cancer; 2012 Mar; 11():17. PubMed ID: 22449259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
    Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
    Zhang Y; Sturgis EM; Huang Z; Zafereo ME; Wei Q; Li G
    Cancer; 2012 Jan; 118(2):485-92. PubMed ID: 21717430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Zhang Y; Sturgis EM; Zafereo ME; Wei Q; Li G
    Cancer; 2011 Mar; 117(6):1227-35. PubMed ID: 21381012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Lei D; Sturgis EM; Wang LE; Liu Z; Zafereo ME; Wei Q; Li G
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1484-91. PubMed ID: 20501759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Zafereo ME; Sturgis EM; Liu Z; Wang LE; Wei Q; Li G
    Carcinogenesis; 2009 Jun; 30(6):997-1002. PubMed ID: 19369580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Li F; Sturgis EM; Chen X; Zafereo ME; Wei Q; Li G
    Cancer; 2010 May; 116(10):2350-9. PubMed ID: 20225330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
    Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.